Stocks & Investing
Wed, September 4, 2024
Fri, May 31, 2024
[ Fri, May 31st 2024
] - WOPRAI
Tue, June 6, 2023
[ Tue, Jun 06th 2023
] - WOPRAI
Thu, May 25, 2023
[ Thu, May 25th 2023
] - WOPRAI
Thu, March 30, 2023
[ Thu, Mar 30th 2023
] - WOPRAI
Tue, March 28, 2023
[ Tue, Mar 28th 2023
] - WOPRAI
Mon, March 20, 2023
[ Mon, Mar 20th 2023
] - WOPRAI
Thu, March 2, 2023
[ Thu, Mar 02nd 2023
] - WOPRAI
Tue, December 20, 2022
[ Tue, Dec 20th 2022
] - WOPRAI
Fri, December 2, 2022
[ Fri, Dec 02nd 2022
] - WOPRAI
Wed, October 5, 2022
[ Wed, Oct 05th 2022
] - WOPRAI
Fri, September 9, 2022
[ Fri, Sep 09th 2022
] - WOPRAI
Fri, July 15, 2022
[ Fri, Jul 15th 2022
] - WOPRAI
Tue, May 10, 2022
[ Tue, May 10th 2022
] - WOPRAI
Fri, March 26, 2021
[ Fri, Mar 26th 2021
] - WOPRAI
Wed, February 3, 2021
Mon, January 11, 2021
[ Mon, Jan 11th 2021
] - WOPRAI
Thu, February 21, 2019
[ Thu, Feb 21st 2019
] - WOPRAI
Tue, August 7, 2018
[ Tue, Aug 07th 2018
] - WOPRAI
Tue, October 17, 2017
Fri, June 30, 2017
Mon, May 22, 2017
[ Mon, May 22nd 2017
] - WOPRAI
Thomas Shrader Downgraded (ATHA) to Hold on, Sep 4th, 2024
Thomas Shrader of BTIG, Downgraded "Athira Pharma, Inc." (ATHA) to Hold on, Sep 4th, 2024.
Thomas has made no other calls on ATHA in the last 4 months.
There is 1 other peer that has a rating on ATHA. Out of the 1 peers that are also analyzing ATHA, 0 agree with Thomas's Rating of Hold.
This is the rating of the analyst that currently disagrees with Thomas
- Elemer Piros of "Rodman & Renshaw" Initiated at Strong Buy and Held Target at $22 on, Monday, August 19th, 2024
